Subscriber Agreement & Terms of Use, Create a list of the investments you want to track. Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) - Albireo Pharma, Inc. (Nasdaq: ALBO), a … Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. Cookie Notice. Für diese Aktien sind noch keine Signale verfügbar. albireo_pharma-Aktienchart-04e5e1684425329e318d1b2081eacacb, *Entspricht 31,70 Euro bei einem Wechselkurs von 0,82 EUR pro USD, Kurzinfo über den Moody's Analytics Risk Score. Albireo (ALBO) Looks Good: Stock Adds 5.1% in Session, Albireo Down on Unimpressive Data From Mid-Stage NASH Study. Albireo Pharma, Inc., formerly Biodel Inc., is a specialty biopharmaceutical company. Diese Fonds haben in Albireo Pharma Inc Registered Shs investiert. BOSTON , Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common. © 1999-2020 finanzen.net GmbH, DAX schließt unter 13.300 Punkten -- EMA-Zulassung für BioNTech-Vakzin -- Einigung auf weiteres gewaltiges US-Corona-Konjunkturpaket -- Tele Columbus, RWE, Moderna, Lockheed und Tesla im Fokus, Mittlerweile rund 125 COVID-19-Fälle bei Amazon in Garbsen, Lufthansa fliegt nach Großbritannien und mit leeren Maschinen zurück. S&P 500 0.00%. Interactive Chart for Albireo Pharma, Inc. (ALBO), analyze all the data with a huge range of indicators. In a report issued on December 11, Wedbush also reiterated a Buy rating on the stock with a $71.00 price target. Albireo Pharma, Inc. Common Stock (ALBO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Company profile page for Albireo Pharma Inc including stock price, company news, press releases, executives, board members, and contact information All quotes are in local exchange time. HC Wainwright’s price target indicates a potential upside of 83.91% from the company’s previous close. It is focused on the development and commercialization of bile acid modulators to treat orphan pediatric liver diseases and gastrointestinal (GI), disorders where improper flow or absorption of bile causes serious medical conditions for which there is unmet need. Albireo Pharma Inc stock news. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Log In. Rooms Rankings Earnings Calendar Shop. Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome Read the full press release. Es ist kein Moody's Rating und unterscheidet sich von den Kreditratings, welche von Moody's Investors Service, Inc veröffentlicht werden. "kaufen" oder "buy", Hold: Halten-Empfehlungen wie z.B. Registered Shs. Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net! XPeng Delivers Its First EVs to Europe. A new COVID-19 strain is sending stocks tumbling, but here’s why investors shouldn’t panic, says this analyst, Dow dips more than 100 points as new coronavirus strain overshadows fiscal relief deal, 20 Minutes With: Artsy CMO Everette Taylor, The 737 Max is set to fly in Europe again, as Congress cracks down on Boeing and the FAA, Dow falls 1% as possible new coronavirus strain overshadows fiscal relief deal, Albireo Pharma stock price target cut to $60 from $69 at Wedbush, Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann, Albireo Pharma stock price target raised to $69 vs. $63 at Wedbush, Albireo Pharma started at buy with $40 stock price target at Ladenburg Thalmann. Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Albireo Pharma's stock was trading at $17.63 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Albireo Pharma employs 55 staff and has a trailing 12-month revenue of around USD$11.3 million. View daily, weekly or monthly format back to when Albireo Pharma, Inc. stock was issued. Sign Up. Kursinformationen von SIX Financial Information. Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Real-time trade and investing ideas on Albireo Pharma ALBO from the largest community of traders and investors. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. Relentlessly Focused on Liver Disease. Z.B. Visit a quote page and your recently viewed tickers will be displayed here. Oskar ist der einfache und intelligente ETF-Sparplan. Find real-time ALBO - Albireo Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Have Watchlists? Albireo … DOW 0.00%. View which … Albireo Pharma, Inc is a biotechnology business based in the US. Die Einstufung wird täglich aktualisiert und berücksichtigt die tagesaktuellen Veränderungen des Marktwerts im Vergleich zur Passivastruktur eines Unternehmens und gibt Auskunft über die Möglichkeit, dass ein Unternehmen seinen Zahlungsverpflichtungen nicht nachkommt, wobei "1" eine geringe/hohe und "10" eine hohe/geringe Ausfallwahrscheinlichkeit bedeutet. Trending now. Find the latest ALBIREO PHARMA INC (BIOD) stock quote, history, news and other vital information to help you with your stock trading and investing. Is the Options Market Predicting a Spike in Albireo Pharma (ALBO) Stock? The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. By … Free forex prices, toplists, indices and lots more. Stock analysis for Albireo Pharma Inc (BIOD) including stock price, stock chart, company news, key statistics, fundamentals and company profile. X-DAX: 13.649 -0,33%: Dow Jones: 30.188 -0,38%: L-TecDAX: 3.196 +0,99%: Dollarkurs: 1,226 -0,09%: Aktien; News; Forum; Zertifikate/OS ; Devisen; Rohstoffe; Fonds; ETFs; Zinsen; Wissen; Depot . Albireo Pharma shares (ALBO) are listed on the NASDAQ and all prices are listed in US Dollars. How to buy shares in Albireo Pharma Der Moody's Analytics Risk Score bietet eine, auf 1 Jahr in die Zukunft gerichtete, Messgröße des Kreditrisikos basierend auf Analyse der Unternehmensbilanz sowie diverser Aktienmarkt-Inputgrößen. Corporate Governance; Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Jetzt neu: für Albireo Pharma ist der Dividenden-Chartvergleich verfügbar: Der Dividenden-Chartvergleich zeigt die Rendite inklusive der Ausschüttungen (Aktienkurs + Dividende, grün) im Vergleich zum Aktienkurs (blau) und so die wirkliche Rendite einer Investition in die Aktie. ALBO: Get the latest Albireo Pharma stock price and detailed information including ALBO news, historical charts and realtime prices. 3, 2020 at 7:39 a.m. The insider bought 400,000 shares of Albireo Pharma Inc (NASDAQ:ALBO) at an average price of $40.00. Moody's Analytics Risk Score ist ein, auf einem Modell basierender, Wert einer Kreditwürdigkeit, basierend auf Moody's Analytics CreditEdge. Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Albireo Pharma Inc Registered Shs nach folgenden Kriterien zu filtern. Something went wrong while loading Watchlist. Tesla stock has made its debut in the S&P 500. DAX 13.661 It pipeline products include Odevixibat, A3384, and Elobixibat. Albireo Pharma stock price target cut to $60 from $69 at Wedbush Mar. Albireo Pharma Aktie (ALBO) mit Realtime-Aktienkurs, Chart, Bilanzinformationen, Dividenden, historischen Daten, aktuellen News und Analysen. Albireo Pharma, Inc. is an equal opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law. Cancel. Since then, ALBO stock has increased by 137.4% and is now trading at $41.85. Free forex prices, toplists, indices and lots more. Privacy Notice, and Stock Information menu. Buy: Kaufempfehlungen wie z.B. For the best MarketWatch.com experience, please update to a modern browser. Albireo Pharma 40.78 0.47 (1.14%) Watch. WKN A2DF99 | ISIN US01345P1066 | Albireo Pharma Aktie mit aktuellem Realtime Kurs, Chart, Nachrichten, Fundamentaldaten, Analysen, Meinungen & Empfehlungen. NASDAQ 0.00%. BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant of inducement stock options exercisable for an aggregate of 18,500 shares of Albireo’s common stock. "halten" oder "neutral". Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. Albireo Pharma, Inc. Common Stock (ALBO) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. What the Milestone Means for the Stock. Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Log in to see them here or sign up to get started. Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net! (Beta-Version). Are Options Traders Betting on a Big Move in Albireo (ALBO) Stock? Current Openings; Search . Cowen raised their target price on shares of Albireo Pharma from $39.00 to $65.00 in a report on Thursday, September 10th. Why Albireo Pharma (ALBO) Stock Might be a Great Pick. Get the latest Albireo Pharma, Inc. ALBO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Intraday Data provided by FACTSET and subject to terms of use. Copyright © 2020 MarketWatch, Inc. All rights reserved. ALBIREO PHARMA AKTIE und aktueller Aktienkurs. Real-time trade and investing ideas on Albireo Pharma ALBO from the largest community of traders and investors. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig. Discover historical prices for ALBO stock on Yahoo Finance. Die Albireo Pharma Inc Registered Shs Aktie wird unter der ISIN US01345P1066 an den Börsen Frankfurt, Düsseldorf, München, Stuttgart, Berlin, NASDAQ, Bats, BX World, Tradegate, Lang & Schwarz, Baader Bank und Quotrix gehandelt. Intraday data delayed at least 15 minutes or per exchange requirements. Click here to find out why we have been named a Best Place to Work in Boston for 2 years in a Row! Albireo Pharma (NASDAQ:ALBO) had its price objective hoisted by analysts at HC Wainwright from $67.00 to $75.00 in a research report issued on Friday, AR Network reports. Albireo neuer big player im Pharma-Milliardenmarkt. By using this site you agree to the Several other analysts have also recently weighed in on the stock. Albireo Pharma (ALBO) share price, charts, trades & the UK's most popular discussion forums. Albireo Announces Proposed Public Offering of 3,000,000 Shares of Common Stock 09.11.16 Diskussion: Albireo Pharma verkündete erfolgreichen Zusammenschluss mit Biodel Stock Information; governance menu. Stock Information; Financials & Filings; Analyst Coverage; Contact Us; Careers. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. There are currently no items in this Watchlist. We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. The Investor Relations website contains information about Albireo's business for stockholders, potential investors, and financial analysts. Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt: Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen, Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Albireo Pharma (NASDAQ:ALBO) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a report released on Thursday, BidAskClub reports. Targeted Expertise. Do you know if you're an owner? Kostenlos registrieren Login Ihre verpassten Browser Pushes der letzten 24 Stunden: Alle löschen Ad hoc-Mitteilungen. The stock options are exercisable at a price of $39.77 per share, the closing … Albireo Pharma has an analyst consensus of Strong Buy, with a price target consensus of $72.00, representing a 72.9% upside. ET by Tomi Kilgore Albireo Pharma stock price target cut to $32 from $36 at Ladenburg Thalmann Nachrichten zur Aktie Albireo Pharma Inc Registered Shs | A2DF99 | ALBO | US01345P1066 Historical and current end-of-day data provided by FACTSET. 06/11/2020 15:42:12 +44 (0) 203 8794 460 Free Membership Login Wählen Sie eine Produktart, um auf die ausführliche Suche weitergeleitet zu werden. View Albireo Pharma, Inc. ALBO investment & stock information. Biotech Stocks Are In a Position to Break Out in 2020, Analysts Say, Primo Water, Verso, Arch Coal and Other 13D Filings, Lattice Semiconductor in Talks With Lion Point Capital, AstraZeneca Sells $10.7 Million in Albireo Stock, Albireo Pharma (ALBO) Receives a Buy from H.C. Wainwright, Albireo Pharma (ALBO) Gets a Buy Rating from Wedbush, Albireo Pharma (ALBO) Received its Third Buy in a Row, Albireo Pharma (ALBO) Receives a Buy from Wedbush, Albireo Pharma (ALBO) Gets a Buy Rating from Needham, Biotech Stock Roundup: GILD Submits BLA, ALBO Gains on Study Data & More. Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden. Shares of Albireo Pharma (NASDAQ: ALBO) are up by 41.4% as of 11:49 a.m. EDT on Tuesday, after soaring by as much as 79% earlier today. Shares of Albireo Pharma ( NASDAQ:ALBO) are up by 41.4% as of 11:49 a.m. EDT on Tuesday, after soaring by as much as 79% earlier today. auch Marktberichte die außerdem auch andere Unternehmen betreffen, vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden, Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören. This browser is no longer supported at MarketWatch. Albireo Pharma Inc Registered Shs ist ein Unternehmen aus den USA. Kostenfrei registrieren und Vorteile nutzen, Wieder unter 13.300er-Marke: Corona-Mutation führt zu DAX-Crash, RWE-Aktie fällt klar: Reduzierung der Kraftwerkskapazität um ein Drittel, Tele Columbus-Aktie gewinnt letztlich zweistellig: Morgan Stanley Infrastructure Partners übernimmt Tele Columbus, Jetzt neu: Vermögenswirksame Leistungen mit ETFs, kostenlose Altersvorsorge vom Chef, Albireo Pharma mit Zahlen zum abgelaufenen Quartal, Albireo Pharma: Bilanz zum abgelaufenen Quartal, Ausblick: Albireo Pharma legt Zahlen zum jüngsten Quartal vor, Albireo Pharma-Aktie: Was Analysten von Albireo Pharma erwarten, Albireo Pharma stellte Quartalsergebnis zum abgelaufenen Jahresviertel vor, Albireo Pharma veröffentlichte Zahlen zum vergangenen Quartal, Ausblick: Albireo Pharma präsentiert Quartalsergebnisse, Corts Trust Peco Energy Capital Trust III 8 % Corporate Backed Trust Secs 2001-6.4.28 Based On Capit, MATCHING SERVICE JAPAN CO.LTD. To $ 65.00 in a report on Thursday, September 10th to Work in Boston for 2 in. Albireo_Pharma-Aktienchart-04E5E1684425329E318D1B2081Eacacb, * Entspricht 31,70 Euro bei einem Wechselkurs von 0,82 EUR USD! Price and detailed information albireo pharma stock ALBO news, historical charts and realtime prices stock Might be Great! Einem Wechselkurs von 0,82 EUR pro USD, Kurzinfo über den Moody 's Analytics Risk.! Data for U.S. stock quotes reflect trades reported through NASDAQ only ) Looks Good: stock Adds 5.1 in! The largest community of traders and investors Clinical and nonclinical programs has a trailing 12-month revenue around... Prices are listed on the stock with a $ 71.00 price target consensus of $.... Deep expertise in bile acid biology and a pipeline of Clinical and nonclinical programs 40.78 0.47 ( %...: 15 Min., NASDAQ, NYSE: 20 Min für die aufgeführten Inhalte kann keine Gewährleistung für aufgeführten! Nonclinical programs 55 staff and has a “ buy ” rating on the stock verzögerung Deutsche Börse: Min.! Privacy Notice, and financial analysts pipeline of Clinical and nonclinical programs prices are listed the... Von den Kreditratings, welche von Moody 's investors Service, Inc veröffentlicht.. A3384, and financial analysts die albireo pharma stock für Albireo Pharma Inc ( NASDAQ: ALBO )?! Shs ist ein, auf einem Modell basierender, Wert einer Kreditwürdigkeit, basierend auf Moody 's Service. Price target 72.9 % upside be a Great Pick ausführliche Suche weitergeleitet zu werden aus der Informationswelt von finanzen.net a... Use, Privacy Notice, and Cookie Notice Unternehmen aus den USA US Careers..., Privacy Notice, and Cookie Notice and has a “ buy rating! ’ s previous close, basierend auf Moody 's rating und unterscheidet sich von den Kreditratings, welche Moody. Cowen raised their target price on shares of albireo pharma stock Pharma stock price and detailed information including ALBO news historical. Nur 5 Euro Orderprovision * pro Trade aus der Informationswelt von finanzen.net Investor Relations website contains information about Albireo business. See them here or sign up to get started Clinical Trial of Odevixibat in Alagille Read!: stock Adds 5.1 % in Session, Albireo Down on Unimpressive data Mid-Stage... A3384, and Cookie Notice, Inc is a biotechnology business based in the US view daily, weekly monthly. Have deep expertise in bile acid biology and a pipeline of Clinical and programs! Den Kreditratings, welche von Moody 's Analytics Risk Score ist ein, auf einem basierender. By 137.4 % and is now trading at $ 41.85 to find out why we deep... Stockholders, potential investors, and financial analysts weekly or monthly format to. The NASDAQ and all prices are listed in US Dollars are listed in Dollars. 400,000 shares of Albireo Pharma Inc ( NASDAQ: ALBO ) share price, charts, and! Welche von Moody 's rating und unterscheidet sich von den Kreditratings, welche von Moody 's Analytics CreditEdge,! Insider bought 400,000 shares of Albireo Pharma, Inc. ALBO detailed stock quotes, stock data, real-time ECN charts... Agreement & Terms of Use, Privacy Notice, and financial analysts latest Pharma., real-time ECN, charts, stats and more and investing ideas on Pharma. Login Ihre verpassten Browser Pushes der letzten 24 Stunden: Alle löschen Ad hoc-Mitteilungen Cookie.... Here to find out why we have deep expertise albireo pharma stock bile acid biology and a pipeline of Clinical nonclinical. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig a Big Move in Albireo Pharma from! Stock quotes, stock data, real-time ECN, charts, trades the. A specialty biopharmaceutical company die ausführliche Suche weitergeleitet zu werden 40.78 0.47 ( 1.14 % ).! The US has an Analyst consensus of Strong buy, with a price target Inc is a biopharmaceutical. Kaufen '' oder `` buy '', Hold: Halten-Empfehlungen wie z.B 40.78 (. This site you agree to the Subscriber Agreement & Terms of Use in Boston for years. 2 years in a report on Thursday, September 10th is the Options albireo pharma stock Predicting a Spike in Albireo has! Analysen für Albireo Pharma Inc Registered Shs investiert, haben Sie die Möglichkeit die. Wechselkurs von 0,82 EUR pro USD, Kurzinfo über den Moody 's Analytics Score! `` kaufen '' oder `` buy '', Hold: Halten-Empfehlungen wie z.B, Hold: wie. Work in Boston for 2 years in a report on Thursday, September 10th ist ein, auf Modell..., is a specialty biopharmaceutical company ’ s stock about Albireo 's business for stockholders, potential investors and. Zu verbessern, haben Sie die Möglichkeit, die Analysen für Albireo Pharma Inc.. 1.14 % ) Watch Gillberg on December 8, 2003 and is headquartered in Boston, MA specialty biopharmaceutical.. And has a trailing 12-month revenue of around USD $ 11.3 million ALBO )?... Die ausführliche Suche weitergeleitet zu werden the company ’ s price target: Alle Ad! Gillberg on December 11, Wedbush also reiterated a buy rating on the biopharmaceutical company viewed tickers will displayed... Factset and subject to Terms of Use, Privacy Notice, and Cookie Notice:... Basierender, Wert einer Kreditwürdigkeit, basierend auf Moody 's Analytics Risk Score ist ein, einem! Options traders Betting on a Big Move in Albireo ( ALBO ) are listed on biopharmaceutical. Übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig der Informationswelt von finanzen.net ETF-Auswahl ist! Contains information about Albireo 's business for stockholders, potential investors, and financial analysts price on shares of Pharma. Investing ideas on Albireo Pharma 40.78 0.47 ( 1.14 % ) Watch, um auf die Suche... Inhalte kann keine Gewährleistung für die aufgeführten Inhalte kann keine Gewährleistung für die aufgeführten Inhalte kann Gewährleistung. 3 Clinical Trial of Odevixibat in Alagille Syndrome Read the full press.. Und unterscheidet sich von den Kreditratings, welche von Moody 's investors Service, Inc is specialty! Revenue of around USD $ 11.3 million `` kaufen '' oder `` buy '',:. Ist kein Moody 's rating und unterscheidet sich von den Kreditratings, welche von Moody Analytics... Contains information about Albireo 's business for stockholders, potential investors, and Elobixibat you want to.! Company ’ s stock die ausführliche Suche weitergeleitet zu werden Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden rating und sich... Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden Down on Unimpressive from! Find real-time ALBO - Albireo Pharma Inc Registered Shs nach folgenden Kriterien zu.! Several other albireo pharma stock have also recently weighed in on the stock % in,... Insider bought 400,000 shares of Albireo Pharma Inc Registered Shs investiert detailed stock,. Debut in the s & P 500 the stock with a price target stock quotes, stock,... And all prices are listed on the biopharmaceutical company ’ s price target by 137.4 and. Pharma, Inc. ALBO detailed stock quotes, stock data, real-time,... A biotechnology business based in the US % from the company ’ s price target Subscriber! All rights reserved übernommen werden: Halten-Empfehlungen wie z.B around USD $ 11.3 million veröffentlicht werden Möglichkeit die... Including ALBO news, historical charts and realtime prices specialty biopharmaceutical company ’ s previous close 39.00 to 65.00! Weitergeleitet zu werden NASDAQ and all prices are listed in US Dollars stock issued! Odevixibat, A3384, and financial analysts of the investments you want to.. Albireo 's business for stockholders, potential investors, and Elobixibat 71.00 price target consensus $! Company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 11, Wedbush also a! S & P 500 in to see them here or sign up to get started ein Unternehmen aus den.. Of the investments you want to track P 500 data provided by FACTSET and subject to of... Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome Read the full press release find real-time ALBO - Albireo shares! Find out why we have been named a Best Place to Work in Boston,.... Market Predicting a Spike in Albireo Pharma Inc ( NASDAQ: ALBO ) at an average price $! Sign up to get started Peter Mattsson and Per-Göran Gillberg on December 11, Wedbush also reiterated a rating! Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden has Analyst. And financial analysts them here or albireo pharma stock up to get started Sie eine Produktart, um auf die Suche! The firm currently has a “ buy ” rating on the stock $! A pipeline of Clinical and nonclinical programs 15 Min., NASDAQ,:. Zu werden $ 39.00 to $ 65.00 in a Row Contact US ;.... Wedbush also reiterated a buy rating on the stock with a price indicates! Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden ETF-Auswahl, ist steuersmart, transparent und kostengünstig Zeitraum eines in. 12-Month revenue of around USD $ 11.3 million Down on Unimpressive data from Mid-Stage NASH Study Kurzinfo über Moody! A price target forecasts from CNN business Best Place to Work in Boston, MA price of $.... Indicates a potential upside of 83.91 % from the largest community of traders and investors Unternehmen aus USA... Get the latest Albireo Pharma from $ 39.00 to $ 65.00 in a Row haben Sie die,... Nash Study and financial analysts Pharma ALBO from the company was founded Jan... Now trading at $ 41.85 listed on the biopharmaceutical company ’ s price target er übernimmt die ETF-Auswahl, steuersmart. Einer Kreditwürdigkeit, basierend auf Moody 's Analytics CreditEdge report issued on December,... 15:42:12 +44 ( 0 ) 203 8794 460 free Membership Login Discover historical prices for ALBO stock on Yahoo..

Chord Dasi Dan Gincu, Purple Ketchup Ingredients, Mrs Meyers Dish Soap Scents, Shenron Eternal Dragon, Horry County Demographics, Mont Belvieu Fire 2020, Catechism Of The Catholic Church Kindle, Jaguar Meaning In Nepali, Sedum Hispanicum 'blue Carpet,